Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804349 · ClinicalTrials.gov registry record · Phase 4
Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients
A Phase 4 study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT00804349: Completed Phase 4 study, sponsored by Albert Einstein Healthcare Network.
NCT00804349 is a Phase 4 study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 6 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804349, a Phase 4 study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
Heart Failure affects 5-6 million Americans and there are about 550 thousand new cases of heart failure every year. There are approximately 3 million hospital admission for acute decompensated heart failure with hospital readmission rate of 20% at 30 days and 50% at 60 day, costing up to 20 billion dollars per year. In our previous study we have discovered that sleep disordered breathing is prevalent in 70% of patients with acute decompensated heart failure. We hypothesize that, detection and treatment of sleep disordered breathing in acute decompensated heart failure patients will reduce episodic hypoxic events during acute decompensation and may decrease hospital length of stay and reduce future readmissions.
Primary Outcome
0 participants analyzed. Study closed; PI no longer at the institution. Efforts to have the PI add the required information have been unsuccessful. No study data are available.
Interventions
- DEVICE Autotitrating Positive Airway Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
What the finished NCT00804349 record still lists
NCT00804349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Autotitrating Positive Airway Pressure is the first listed.
NCT00804349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00804349 about?
NCT00804349 is a clinical study titled "Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients". Heart Failure affects 5-6 million Americans and there are about 550 thousand new cases of heart failure every year. There are approximately 3 million hospital admission for acute decompensated heart failure with hospital readmission rate of 20% at 30 days and 50% at 60 day, costing up to 20 billion ...
What is the current status of trial NCT00804349?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2008-10. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00804349?
The interventions under investigation include: Autotitrating Positive Airway Pressure (DEVICE).
Who is sponsoring clinical trial NCT00804349?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00804349's enrollment target sits among peer trials
6 1983rd of 2000 higher than 12 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia